Conmed Corp Earnings

Conmed Corp’s revenue jumped 3.09% since last year same period to $321.26Mn in the Q1 2025. On a quarterly growth basis, Conmed Corp has generated -7.67% fall in its revenue since last 3-months.

Conmed Corp’s net profit fell -69.37% since last year same period to $6.04Mn in the Q1 2025. On a quarterly growth basis, Conmed Corp has generated -82.12% fall in its net profits since last 3-months.

Conmed Corp’s net profit margin fell -70.29% since last year same period to 1.88% in the Q1 2025. On a quarterly growth basis, Conmed Corp has generated -80.63% fall in its net profit margins since last 3-months.

Conmed Corp’s price-to-earnings ratio after this Q1 2025 earnings stands at 13.67.

Conmed Corp’s earning per share (EPS) estimates for the current quarter stand at 0.81 - a -32.52% fall from last quarter’s estimates.

Conmed Corp’s earning per share (EPS) estimates for the current year stand at 0.81.

Conmed Corp’s earning per share (EPS) jumped 20.25% since last year same period to 0.95 in the Q1 2025. This indicates that the Conmed Corp has generated 20.25% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Conmed Corp’s return on assets (ROA) stands at 0.04.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Conmed Corp’s return on equity (ROE) stands at 0.13.

Conmed Corp declared 0.2 dividend per share during the earnings announcement for Q1 2025.